Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study RXP110908, a Polysomnography Study of GSK1838262 (XP13512) Extended Release Tablets Versus Placebo in the Treatment of Restless Legs Syndrome (RLS) and Associated Sleep Disturbance

NCT00748098 is registered in ClinicalTrials.gov with XenoPort, Inc. as lead sponsor.

NCT NCT00748098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00748098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study RXP110908, a Polysomnography Study of GSK1838262 (XP13512) Extended Release Tablets Versus Placebo in the Treatment of Restless Legs Syndrome (RLS) and Associated Sleep Disturbance
Lead sponsor
XenoPort, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2008
Completion date
July 31, 2009
Enrollment
136 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome, restless legs syndrome (rls)